Talaris Therapeutics Inc. (TALS)
NASDAQ: TALS
· Real-Time Price · USD
2.72
-0.02 (-0.73%)
At close: Oct 19, 2023, 10:00 PM
Talaris Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.76 | -0.76 | -0.6 | -0.87 | -1 | -0.43 | -0.22 | -0.09 | -0.07 | -0.15 | -2.56 | -5.52 | -10.99 | -10.65 | -8.86 | -18.02 |
PEG Ratio | -0.67 | 0.01 | 0.00 | -0.06 | n/a | 0.01 | 0.01 | -0.00 | 0.00 | -0.00 | 1.15 | -0.19 | -1.17 | 0.49 | -0.11 | 0.64 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.27 | 0.25 | 0.23 | 0.22 | 0.21 | 0.08 | 0.09 | 0.05 | 0.02 | 0.06 | 0.88 | 1.78 | 2.58 | 2.16 | 1.50 | -14.42 |
P/FCF Ratio | -3.46 | -3.22 | -1.81 | -2.99 | n/a | -1.71 | -0.86 | -0.46 | -0.3 | -0.79 | -10.09 | -22.88 | -56.8 | -50.8 | -35.53 | -72.57 |
P/OCF Ratio | -3.46 | -3.22 | -1.78 | -2.99 | n/a | -1.71 | -0.87 | -0.46 | -0.31 | -0.81 | -10.72 | -24.77 | -63.67 | -54.45 | -36.62 | -74.07 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | n/a | n/a | n/a | n/a |
Quick Ratio | 24.68 | 33.87 | 30.18 | 40.33 | 46.87 | 18.64 | 15.41 | 16.59 | 16.19 | 21.61 | 28.92 | 28.32 | 30.86 | 51.83 | 58.03 | 39.28 |
Current Ratio | 24.68 | 33.87 | 30.18 | 40.33 | 46.87 | 18.64 | 15.41 | 16.59 | 16.19 | 21.61 | 28.92 | 28.32 | 30.86 | 51.83 | 58.03 | 39.88 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | 10.93 | n/a | n/a | -4.66 | -9.35 | n/a | -11.19 | -24.41 | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.09 | -0.08 | -0.1 | -0.06 | -0.05 | -0.05 | -0.1 | -0.13 | -0.08 | -0.09 | -0.09 | -0.08 | -0.06 | -0.05 | -0.04 | 0.20 |
Return on Assets | -0.09 | -0.08 | -0.09 | -0.06 | -0.05 | -0.05 | -0.09 | -0.12 | -0.08 | -0.09 | -0.08 | -0.08 | -0.06 | -0.05 | -0.04 | -0.06 |
Return on Invested Capital | -0.1 | -0.09 | -0.12 | -0.08 | -0.06 | -0.06 | -0.11 | -0.14 | -0.09 | -0.1 | -0.09 | -0.08 | -0.06 | -0.05 | -0.04 | -0.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |